Impact of immunogenicity on clinical efficacy and toxicity profile of biologic agents used for treatment of inflammatory arthritis in children compared to adults

The treatment of inflammatory arthritis has been revolutionised by the introduction of biologic treatments. Many biologic agents are currently licensed for use in both paediatric and adult patients with inflammatory arthritis and contribute to improved disease outcomes compared with the pre-biologic...

Full description

Bibliographic Details
Main Authors:	Chinar R. Parikh, Jaya K. Ponnampalam, George Seligmann, Leda Coelewij, Ines Pineda-Torra, Elizabeth C. Jury, Coziana Ciurtin
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-06-01
Series:	Therapeutic Advances in Musculoskeletal Disease
Online Access:	https://doi.org/10.1177/1759720X211002685

Similar Items

Lipid metabolism in autoimmune rheumatic disease: implications for modern and conventional therapies
by: George Robinson, et al.
Published: (2022-01-01)

CD8+ T-Cells in Juvenile-Onset SLE: From Pathogenesis to Comorbidities
by: Coziana Ciurtin, et al.
Published: (2022-06-01)

Sex Differences in Lipid Metabolism: Implications for Systemic Lupus Erythematosus and Cardiovascular Disease Risk
by: George A. Robinson, et al.
Published: (2022-05-01)

Metabolomics Defines Complex Patterns of Dyslipidaemia in Juvenile-SLE Patients Associated with Inflammation and Potential Cardiovascular Disease Risk
by: George A. Robinson, et al.
Published: (2021-12-01)

Challenges in Implementing Cardiovascular Risk Scores for Assessment of Young People With Childhood-Onset Autoimmune Rheumatic Conditions
by: Coziana Ciurtin, et al.
Published: (2022-02-01)

Sex hormones drive changes in lipoprotein metabolism
by: George A. Robinson, et al.
Published: (2021-11-01)

Editorial: Sex bias in autoimmunity: From animal models to clinical research and applications
by: George A. Robinson, et al.
Published: (2022-12-01)

CD8<sup>+</sup> T Cell Phenotype and Function in Childhood and Adult-Onset Connective Tissue Disease
by: Anna Radziszewska, et al.
Published: (2022-09-01)

Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFNβ
by: Kirsty E. Waddington, et al.
Published: (2020-07-01)

Multi-Omic Biomarkers for Patient Stratification in Sjogren’s Syndrome—A Review of the Literature
by: Lucia Martin-Gutierrez, et al.
Published: (2022-07-01)

Blood metabolomic and transcriptomic signatures stratify patient subgroups in multiple sclerosis according to disease severity
by: Alexandra E. Oppong, et al.
Published: (2024-03-01)

Impact of puberty, sex determinants and chronic inflammation on cardiovascular risk in young people
by: Amal Allalou, et al.
Published: (2023-06-01)

Exploring the Evidence for an Immunomodulatory Role of Vitamin D in Juvenile and Adult Rheumatic Disease
by: Jiaqi Zou, et al.
Published: (2021-02-01)

Letter to the Editor in response to Chen et al. 2020
by: Jaya Ponnampalam, et al.
Published: (2020-11-01)

Biomarkers of Response to Biologic Therapy in Juvenile Idiopathic Arthritis
by: Varvara Choida, et al.
Published: (2021-02-01)

The impact of immunocompromise on outcomes of COVID-19 in children and young people—a systematic review and meta-analysis
by: James Greenan-Barrett, et al.
Published: (2023-08-01)

Gender-Diverse Inclusion in Immunological Research: Benefits to Science and Health
by: Hannah Peckham, et al.
Published: (2022-07-01)

O26 First investigation of the performance of validated cardiovascular risk scores in a global (UK/USA) cohort of children, adolescents, and young adults with juvenile-onset systemic lupus erythematosus
by: Laura E Schanberg, et al.
Published: (2024-03-01)

Similarities and Differences Between Juvenile and Adult Spondyloarthropathies
by: Corinne Fisher, et al.
Published: (2021-05-01)

Transcriptional Regulation of T-Cell Lipid Metabolism: Implications for Plasma Membrane Lipid Rafts and T-Cell Function
by: George A. Robinson, et al.
Published: (2017-11-01)

Humoral and cellular immunogenicity of COVID-19 booster dose vaccination in inflammatory arthritis patients
by: Jakub Wroński, et al.
Published: (2022-10-01)

Editorial: Immunogenicity of Proteins Used as Therapeutics
by: Zuben E. Sauna, et al.
Published: (2020-10-01)

Immunogenicity and toxicity of AAV gene therapy
by: Hildegund C. J. Ertl
Published: (2022-08-01)

Disrupted Lipid Metabolism in Multiple Sclerosis: A Role for Liver X Receptors?
by: Inés Pineda-Torra, et al.
Published: (2021-04-01)

Marital Status and Gender Differences as Key Determinants of COVID-19 Impact on Wellbeing, Job Satisfaction and Resilience in Health Care Workers and Staff Working in Academia in the UK During the First Wave of the Pandemic
by: Junjie Peng, et al.
Published: (2022-06-01)

A Systematic Review and Meta-Analysis of Anti-Rheumatic Drugs and Pneumococcal Vaccine Immunogenicity in Inflammatory Arthritis
by: Deepak Nagra, et al.
Published: (2023-11-01)

Immunogenicity to biological drugs in psoriasis and psoriatic arthritis
by: Fernando Valenzuela, et al.
Published: (2021-10-01)

SB5 shows cross-immunogenicity to adalimumab but not infliximab: results in patients with inflammatory bowel disease or rheumatoid arthritis
by: Joao Goncalves, et al.
Published: (2019-12-01)

Editorial: Immunogenicity and toxicity of AAV gene therapy
by: Allison Bradbury, et al.
Published: (2023-06-01)

Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis
by: Takacs P, et al.
Published: (2019-01-01)

Immunogenicity of biologics in inflammatory bowel disease
by: Séverine Vermeire, et al.
Published: (2018-01-01)

Epithelial transport of immunogenic and toxic gliadin peptides in vitro.
by: Christian Zimmermann, et al.
Published: (2014-01-01)

LYMPHOCYTIC IMMUNO-INFLAMMATORY STATUS IN PATIENTS WITH PARASITIC ARTHRITIS DEPENDING ON THE ETIOLOGICAL AGENT
by: Maia Grosu, et al.
Published: (2023-08-01)

S03.3 Patient-specific and disease-related determinants for cardiovascular disease (CVD) risk stratification in the apple (atherosclerosis prevention in paediatric lupus erythematosus) clinical trial cohort
by: G Robinson, et al.
Published: (2022-10-01)

Evaluation of Toxicity and Efficacy of Inotodiol as an Anti-Inflammatory Agent Using Animal Model
by: Thi Minh Nguyet Nguyen, et al.
Published: (2022-07-01)

Immunogenicity induced by biologicals in the treatment of psoriasis and psoriatic arthritis: View of the problem
by: T. V. Korotaeva
Published: (2016-01-01)

1871 Aligning national and local data to predict clinic non-attendance in adolescent and young adult rheumatology using machine learning model
by: Coziana Ciurtin, et al.
Published: (2022-12-01)

TRPM3 channel stimulated by pregnenolone sulphate in synovial fibroblasts and negatively coupled to hyaluronan
by: English Anne A, et al.
Published: (2010-06-01)

Immunogenicity of cholera vaccination in children with inflammatory bowel disease
by: Łukasz Dembiński, et al.
Published: (2021-08-01)

Golimumab in the treatment of inflammatory diseases: A role of immunogenicity
by: D. E. Karateev
Published: (2016-01-01)